Normal hemostasis involves three key steps: vessel constriction and formation of a platelet plug to stop bleeding (primary hemostasis), activation of the clotting cascade and deposition of fibrin to stabilize the platelet plug (secondary hemostasis), and dissolution of the fibrin clot and removal of the plug (tertiary hemostasis). Bleeding disorders can result from abnormalities in blood vessels, platelets, or clotting factors. Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder where autoantibodies cause accelerated platelet destruction, which can lead to dangerous bleeding especially intracerebral hemorrhage when platelet counts fall below 20,000.
1. An infarction is an area of ischemic necrosis in an organ resulting from reduced blood supply, usually due to arterial obstruction.
2. The main causes of infarction are thromboembolism and atherosclerosis, which interrupt arterial blood flow. This leads to localized tissue death from coagulative necrosis.
3. Pathologically, infarcts appear pale and wedge-shaped, with inflammation at the borders and eventual scar formation. Location and outcomes vary by organ, such as potentially lethal myocardial infarction or non-lethal splenic infarction.
This document discusses chronic venous congestion (CVC) and its effects on various organs. It describes how CVC results in localized blood volume increase within dilated vessels. It then summarizes the gross and microscopic findings of CVC in the lungs, liver, spleen, and kidneys. The lungs show brown induration and thickened alveolar septa. The liver has a nutmeg appearance and centrilobular necrosis. The spleen exhibits congestion and fibrosis. The kidneys demonstrate mild degenerative changes. Hemorrhage and its causes, effects based on amount/speed of blood loss are also outlined.
1) Myocardial infarction, cerebral infarction, pulmonary infarction, and gangrene of limbs are common examples of infarction that result from obstruction of blood flow.
2) Infarctions are typically wedge-shaped areas of ischemic necrosis caused by occlusion of the arterial blood supply or venous drainage of a tissue.
3) The development of an infarction depends on factors like the nature of the blood supply, the rate of occlusion, the tissue's vulnerability to hypoxia, and the oxygen content of the blood. Tissues with dual blood supplies are less likely to infarct.
Haemodynamic disorders , thromboembolism and shock by Dr Nadeem (RMC)Hassan Ahmad
The document discusses various haemodynamic disorders including thrombosis, embolism, shock, hyperemia, congestion, and edema. It provides details on the pathophysiology and morphological changes seen in these conditions.
Hyperemia is an active process resulting from increased blood flow due to arteriolar dilation, causing engorged tissue that appears red. Congestion is a passive process resulting from impaired outflow, causing tissue to appear bluish-red due to accumulation of deoxygenated blood.
Pulmonary congestion microscopically shows engorged alveolar capillaries and edema, while chronic pulmonary congestion shows thickened fibrotic septa and hemosiderin
Hemostasis and blood coagulation general pathologySiganga Siganga
1) Hemostasis maintains blood fluidity while forming clots at injury sites through platelet activation and coagulation.
2) Primary hemostasis involves platelet adhesion and aggregation to form a platelet plug. Secondary hemostasis activates coagulation and thrombin to form a fibrin-based thrombus.
3) The coagulation cascade is tightly regulated by anticoagulants like antithrombin III, protein C and S, and tissue factor pathway inhibitor to restrict clotting to sites of injury.
aetiology of inflammation; types of inflammation; how inflammation occur; cells involve in inflammation; role of wbc in inflammation; outcome of inflammation; how inflammation associated with immunity, clotting system, complementary system kinin system, how inflammation is associated with oral cavity; disease associated with inflammatory system
Normal hemostasis involves three key steps: vessel constriction and formation of a platelet plug to stop bleeding (primary hemostasis), activation of the clotting cascade and deposition of fibrin to stabilize the platelet plug (secondary hemostasis), and dissolution of the fibrin clot and removal of the plug (tertiary hemostasis). Bleeding disorders can result from abnormalities in blood vessels, platelets, or clotting factors. Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder where autoantibodies cause accelerated platelet destruction, which can lead to dangerous bleeding especially intracerebral hemorrhage when platelet counts fall below 20,000.
1. An infarction is an area of ischemic necrosis in an organ resulting from reduced blood supply, usually due to arterial obstruction.
2. The main causes of infarction are thromboembolism and atherosclerosis, which interrupt arterial blood flow. This leads to localized tissue death from coagulative necrosis.
3. Pathologically, infarcts appear pale and wedge-shaped, with inflammation at the borders and eventual scar formation. Location and outcomes vary by organ, such as potentially lethal myocardial infarction or non-lethal splenic infarction.
This document discusses chronic venous congestion (CVC) and its effects on various organs. It describes how CVC results in localized blood volume increase within dilated vessels. It then summarizes the gross and microscopic findings of CVC in the lungs, liver, spleen, and kidneys. The lungs show brown induration and thickened alveolar septa. The liver has a nutmeg appearance and centrilobular necrosis. The spleen exhibits congestion and fibrosis. The kidneys demonstrate mild degenerative changes. Hemorrhage and its causes, effects based on amount/speed of blood loss are also outlined.
1) Myocardial infarction, cerebral infarction, pulmonary infarction, and gangrene of limbs are common examples of infarction that result from obstruction of blood flow.
2) Infarctions are typically wedge-shaped areas of ischemic necrosis caused by occlusion of the arterial blood supply or venous drainage of a tissue.
3) The development of an infarction depends on factors like the nature of the blood supply, the rate of occlusion, the tissue's vulnerability to hypoxia, and the oxygen content of the blood. Tissues with dual blood supplies are less likely to infarct.
Haemodynamic disorders , thromboembolism and shock by Dr Nadeem (RMC)Hassan Ahmad
The document discusses various haemodynamic disorders including thrombosis, embolism, shock, hyperemia, congestion, and edema. It provides details on the pathophysiology and morphological changes seen in these conditions.
Hyperemia is an active process resulting from increased blood flow due to arteriolar dilation, causing engorged tissue that appears red. Congestion is a passive process resulting from impaired outflow, causing tissue to appear bluish-red due to accumulation of deoxygenated blood.
Pulmonary congestion microscopically shows engorged alveolar capillaries and edema, while chronic pulmonary congestion shows thickened fibrotic septa and hemosiderin
Hemostasis and blood coagulation general pathologySiganga Siganga
1) Hemostasis maintains blood fluidity while forming clots at injury sites through platelet activation and coagulation.
2) Primary hemostasis involves platelet adhesion and aggregation to form a platelet plug. Secondary hemostasis activates coagulation and thrombin to form a fibrin-based thrombus.
3) The coagulation cascade is tightly regulated by anticoagulants like antithrombin III, protein C and S, and tissue factor pathway inhibitor to restrict clotting to sites of injury.
aetiology of inflammation; types of inflammation; how inflammation occur; cells involve in inflammation; role of wbc in inflammation; outcome of inflammation; how inflammation associated with immunity, clotting system, complementary system kinin system, how inflammation is associated with oral cavity; disease associated with inflammatory system
Acute inflammation is the immediate response to tissue injury and involves vasodilation, increased vascular permeability leading to edema, and leukocyte emigration. The key events in acute inflammation are vascular changes, leukocyte migration into tissues, and the release of chemical mediators. Chronic inflammation is a prolonged inflammatory response involving lymphocytes, macrophages and plasma cells that can lead to tissue destruction and attempts at repair through fibrosis. [/SUMMARY]
Thrombosis is the formation of a blood clot within a blood vessel or cavity of the heart. Virchow identified three main factors that contribute to thrombosis: endothelial injury, changes in blood flow, and hypercoagulability. Thrombi can propagate or embolize, becoming lodged in another vessel and resulting in infarction of downstream tissue. Infarctions appear pale/white in solid organs and red/hemorrhagic in lungs/other tissues. Over time, infarcted tissue progresses from coagulative necrosis to phagocytosis and scar formation.
The document discusses various hemodynamic disorders including hyperemia, congestion, thrombosis, embolism, and infarction. Hyperemia is an increased blood volume in tissue from vasodilation. Congestion is increased blood volume from impaired venous return. Thrombosis is the formation of a blood clot within vessels. An embolism occurs when a piece of thrombus or other material blocks a vessel. Infarction is tissue death from blocked arteries or veins.
1. The document describes the different morphological patterns of acute inflammation including serous, fibrinous, suppurative, hemorrhagic, catarrhal, membranous, and necrotizing inflammation.
2. It also discusses the systemic effects of acute inflammation known as the acute phase response, including fever, increased acute phase proteins, and changes in white blood cells.
3. The fates of acute inflammation are described as resolution, healing, suppuration, or progression to chronic inflammation.
Chronic inflammation can last for months or years and is driven by macrophages and lymphocytes. It can be caused by persistent infections, autoimmune reactions, and foreign bodies. Activated macrophages and T cells secrete cytokines and growth factors that lead to tissue damage and fibrosis over time. Macrophages and T cells also interact and stimulate each other, prolonging the inflammatory response. Granulomas are clusters of macrophages that form in response to chronic inflammation and surround foreign materials to isolate them.
1. An infarct is a localized area of ischemic necrosis that occurs in a tissue or organ due to impaired arterial blood supply or venous drainage.
2. Causes of infarcts include occlusion of arteries or veins from thrombosis, embolism, atherosclerotic plaques, or external compression, as well as spasm of arterioles.
3. There are three main types of infarcts: white (anemic) infarcts caused by arterial occlusion in organs with few collaterals; red (hemorrhagic) infarcts caused by arterial or venous occlusion in loose tissues; and septic infarcts caused by bacteria-containing emboli.
Thrombosis is the formation of a blood clot (thrombus) inside a blood vessel, obstructing blood flow. It can cause serious complications in organs like the brain and lungs. A thrombus forms through platelet adhesion and aggregation at the site of injury, followed by coagulation and fibrin formation around the platelet plug. Virchow's triad outlines the factors of abnormal blood flow, endothelial dysfunction, and hypercoagulability that contribute to thrombosis. Venous thrombosis typically occurs in the leg veins, while arterial thrombosis is often associated with atherosclerosis and causes such events as myocardial infarction.
This document discusses circulatory disturbances and disturbances of blood and body fluids. It covers topics such as hyperaemia and congestion, thrombosis, and venous thrombosis.
Hyperaemia is an increase in blood flow due to vessel dilation, while congestion is passive hyperaemia due to blood engorgement in veins. Thrombosis is the formation of a blood clot within a vessel. It can be caused by endothelial injury, abnormal blood flow, and hypercoagulability. Venous thrombosis commonly occurs in the lower limbs and is due to stasis, hypercoagulability, and endothelial damage. Migratory thrombophlebitis is associated with disseminated cancers. Capillary thrombosis
Thrombosis is the formation of a blood clot or thrombus within a blood vessel. Virchow's triad describes the key factors that predispose to thrombosis: endothelial injury, altered blood flow, and hypercoagulability. Thrombosis occurs through platelet activation and aggregation, and activation of the coagulation cascade following vascular injury. Thrombi can cause ischemic injury by blocking blood flow or thromboembolism by dislodging and blocking vessels downstream. The fate of a thrombus includes resolution, organization, propagation or thromboembolism.
Hemodynamic disorders, thrombosis and shock (practical pathology)Mohaned Lehya
This document discusses hemodynamic disorders and thrombosis. It covers several topics including edema, congestion, hemorrhage, thrombosis, embolism, and infarction. Edema is an accumulation of fluid in tissues and organs, and can occur in the lungs (pulmonary edema), abdomen (ascites), and brain. Congestion and hyperemia involve increased blood volume in organs and tissues, seen in conditions like heart failure and liver disease. Thrombosis is the formation of a clot (thrombus) in a blood vessel. Key factors in thrombosis are described by Virchow's triad. Thrombi can embolize and block vessels in other organs, potentially leading to infarction or tissue death.
Bleeding and coagulation disorders hemostasisShams Patel
1) Hemostasis is the process by which blood maintains its fluid state within vessels but also forms clots at sites of injury. It involves vasoconstriction, platelet plug formation, and coagulation cascade.
2) For blood not to clot normally in circulation, the endothelium prevents platelet adhesion, negatively charged particles repel clotting factors, circulation velocity must decrease for clotting, and natural anticoagulants and fibrinolysis are present.
3) Coagulation occurs through the intrinsic and extrinsic pathways activating prothrombin to thrombin which converts fibrinogen to fibrin threads forming a clot.
Normal hemostasis involves maintaining blood fluidity within vessels and forming a hemostatic plug to stop bleeding from injuries. It has three key steps - vasoconstriction, formation of a primary platelet plug, and a secondary fibrin clot formed by the coagulation cascade. The body regulates this process through anticoagulants like antithrombin III, protein C and S, and TFPI to restrict clotting locally. It also activates fibrinolysis through plasmin to limit final clot size.
This document discusses hemostasis, the process by which bleeding is stopped. It describes the two main components: primary hemostasis involving platelet adhesion, aggregation, and plug formation; and secondary hemostasis where insoluble fibrin is generated through coagulation cascade reactions to strengthen the platelet plug. Key terms are defined, including hemostasis, thrombosis, hemorrhage, and coagulopathy. The roles of primary hemostasis, secondary hemostasis, the intrinsic pathway, extrinsic pathway, and common pathway in the coagulation cascade are explained.
This document discusses infarction, which is localized ischemic necrosis of tissue due to decreased blood supply. Infarction can be caused by thrombi, emboli, vasospasm, expansion of atheroma, extrinsic compression of vessels, vessel twisting, or traumatic vessel rupture. There are three main types of infarction: red (hemorrhagic), white (anemic), and septic. Factors that influence infarction development include vulnerability to hypoxia, blood oxygen content, rate of occlusion, and blood supply. Myocardial, pulmonary, and cerebral infarctions are provided as examples and their characteristics and outcomes described.
This document summarizes different types of thrombosis and embolism. It discusses thrombosis, thrombus formation, and the coagulation cascade. It also covers different causes of endothelial injury that can lead to thrombosis, including atherosclerosis, hypertension, diabetes, and smoking. Alterations in blood flow that can promote thrombosis are turbulence, stasis, and hypercoagulability. The document outlines various types of embolism including thromboembolism, fat embolism, gas embolism, and amniotic fluid embolism. It provides details on the pathogenesis, clinical manifestations, and consequences of pulmonary thromboembolism and systemic arterial embolism.
Thrombosis results from an imbalance in the normal hemostatic system where there is inappropriate clot formation. It depends on contributions from Virchow's triad of endothelial injury, abnormal blood flow, and hypercoagulability. Endothelial damage or abnormalities in blood flow like stasis or turbulence allow clots to form. Hypercoagulable states like genetic mutations or inflammation also promote clotting. Thrombi may propagate and cause tissue injury, become organized, or embolize to distant sites. Disseminated intravascular coagulation is a consumptive coagulopathy where widespread microvascular thrombi activate fibrinolysis, initially causing thrombosis but potentially evolving into bleeding.
Hemostasis is the arrest of bleeding, whether it be by normal vasoconstriction (the vessel walls closing temporarily), by an abnormal obstruction (such as a plaque) or by coagulation or surgical means (such as ligation)
This document summarizes hemostasis, the process by which bleeding is stopped. It discusses the three components of hemostasis - extravascular, vascular, and intravascular. The normal hemostasis process involves platelet plug formation and fibrin clot formation via the coagulation cascade. Coagulation factors, platelets, and fibrinogen are involved. Hemostasis is balanced by natural anticoagulants. Genetic or acquired bleeding disorders can result from deficiencies in specific coagulation factors or platelets. Common disorders discussed include hemophilia A/B/C and von Willebrand disease.
The document discusses various hemodynamic disorders including hyperemia, congestion, thrombosis, embolism, and infarction. Hyperemia is an increased blood volume in tissue from vasodilation. Congestion is increased blood volume from impaired venous return. Thrombosis is the formation of a blood clot within vessels. An embolism occurs when a piece of thrombus or other material blocks a vessel. Infarction is tissue death from blocked arteries or veins.
Hemostasis definition, types and steps.
Hemostasis and coagulation physiology and pathology in steps and illustrated in simple way by diagrams.
Intrinsic and extrinsic pathways are mentioned in details.
Platelet function as a corner stone hemostasis in case of endothelial injury or another pathology taht affect endothelium or blood vessels.
Some pharmacological notes about drugs related to hemostasis and its clinical significance.
The document discusses thrombosis and embolism. It defines thrombosis as the formation of a blood clot within a blood vessel and embolism as a detached blood clot that travels through the bloodstream. It covers topics like the mechanisms of hemostasis (clot formation), factors that predispose to thrombosis, morphology of arterial and venous thrombi, types of thrombosis like deep vein thrombosis and their clinical presentations.
Hemostasis and thrombosis involve the regulation of blood clotting. Normal hemostasis maintains blood fluidity but allows clotting at sites of injury. Thrombosis is pathological clotting in uninjured or minimally injured vessels. It involves platelet adhesion and activation, coagulation cascade activation, and fibrin clot formation. Counter-regulatory mechanisms normally limit clotting to the injury site. Abnormalities in blood components, vessel walls, or flow can cause hypercoagulability and thrombosis.
Acute inflammation is the immediate response to tissue injury and involves vasodilation, increased vascular permeability leading to edema, and leukocyte emigration. The key events in acute inflammation are vascular changes, leukocyte migration into tissues, and the release of chemical mediators. Chronic inflammation is a prolonged inflammatory response involving lymphocytes, macrophages and plasma cells that can lead to tissue destruction and attempts at repair through fibrosis. [/SUMMARY]
Thrombosis is the formation of a blood clot within a blood vessel or cavity of the heart. Virchow identified three main factors that contribute to thrombosis: endothelial injury, changes in blood flow, and hypercoagulability. Thrombi can propagate or embolize, becoming lodged in another vessel and resulting in infarction of downstream tissue. Infarctions appear pale/white in solid organs and red/hemorrhagic in lungs/other tissues. Over time, infarcted tissue progresses from coagulative necrosis to phagocytosis and scar formation.
The document discusses various hemodynamic disorders including hyperemia, congestion, thrombosis, embolism, and infarction. Hyperemia is an increased blood volume in tissue from vasodilation. Congestion is increased blood volume from impaired venous return. Thrombosis is the formation of a blood clot within vessels. An embolism occurs when a piece of thrombus or other material blocks a vessel. Infarction is tissue death from blocked arteries or veins.
1. The document describes the different morphological patterns of acute inflammation including serous, fibrinous, suppurative, hemorrhagic, catarrhal, membranous, and necrotizing inflammation.
2. It also discusses the systemic effects of acute inflammation known as the acute phase response, including fever, increased acute phase proteins, and changes in white blood cells.
3. The fates of acute inflammation are described as resolution, healing, suppuration, or progression to chronic inflammation.
Chronic inflammation can last for months or years and is driven by macrophages and lymphocytes. It can be caused by persistent infections, autoimmune reactions, and foreign bodies. Activated macrophages and T cells secrete cytokines and growth factors that lead to tissue damage and fibrosis over time. Macrophages and T cells also interact and stimulate each other, prolonging the inflammatory response. Granulomas are clusters of macrophages that form in response to chronic inflammation and surround foreign materials to isolate them.
1. An infarct is a localized area of ischemic necrosis that occurs in a tissue or organ due to impaired arterial blood supply or venous drainage.
2. Causes of infarcts include occlusion of arteries or veins from thrombosis, embolism, atherosclerotic plaques, or external compression, as well as spasm of arterioles.
3. There are three main types of infarcts: white (anemic) infarcts caused by arterial occlusion in organs with few collaterals; red (hemorrhagic) infarcts caused by arterial or venous occlusion in loose tissues; and septic infarcts caused by bacteria-containing emboli.
Thrombosis is the formation of a blood clot (thrombus) inside a blood vessel, obstructing blood flow. It can cause serious complications in organs like the brain and lungs. A thrombus forms through platelet adhesion and aggregation at the site of injury, followed by coagulation and fibrin formation around the platelet plug. Virchow's triad outlines the factors of abnormal blood flow, endothelial dysfunction, and hypercoagulability that contribute to thrombosis. Venous thrombosis typically occurs in the leg veins, while arterial thrombosis is often associated with atherosclerosis and causes such events as myocardial infarction.
This document discusses circulatory disturbances and disturbances of blood and body fluids. It covers topics such as hyperaemia and congestion, thrombosis, and venous thrombosis.
Hyperaemia is an increase in blood flow due to vessel dilation, while congestion is passive hyperaemia due to blood engorgement in veins. Thrombosis is the formation of a blood clot within a vessel. It can be caused by endothelial injury, abnormal blood flow, and hypercoagulability. Venous thrombosis commonly occurs in the lower limbs and is due to stasis, hypercoagulability, and endothelial damage. Migratory thrombophlebitis is associated with disseminated cancers. Capillary thrombosis
Thrombosis is the formation of a blood clot or thrombus within a blood vessel. Virchow's triad describes the key factors that predispose to thrombosis: endothelial injury, altered blood flow, and hypercoagulability. Thrombosis occurs through platelet activation and aggregation, and activation of the coagulation cascade following vascular injury. Thrombi can cause ischemic injury by blocking blood flow or thromboembolism by dislodging and blocking vessels downstream. The fate of a thrombus includes resolution, organization, propagation or thromboembolism.
Hemodynamic disorders, thrombosis and shock (practical pathology)Mohaned Lehya
This document discusses hemodynamic disorders and thrombosis. It covers several topics including edema, congestion, hemorrhage, thrombosis, embolism, and infarction. Edema is an accumulation of fluid in tissues and organs, and can occur in the lungs (pulmonary edema), abdomen (ascites), and brain. Congestion and hyperemia involve increased blood volume in organs and tissues, seen in conditions like heart failure and liver disease. Thrombosis is the formation of a clot (thrombus) in a blood vessel. Key factors in thrombosis are described by Virchow's triad. Thrombi can embolize and block vessels in other organs, potentially leading to infarction or tissue death.
Bleeding and coagulation disorders hemostasisShams Patel
1) Hemostasis is the process by which blood maintains its fluid state within vessels but also forms clots at sites of injury. It involves vasoconstriction, platelet plug formation, and coagulation cascade.
2) For blood not to clot normally in circulation, the endothelium prevents platelet adhesion, negatively charged particles repel clotting factors, circulation velocity must decrease for clotting, and natural anticoagulants and fibrinolysis are present.
3) Coagulation occurs through the intrinsic and extrinsic pathways activating prothrombin to thrombin which converts fibrinogen to fibrin threads forming a clot.
Normal hemostasis involves maintaining blood fluidity within vessels and forming a hemostatic plug to stop bleeding from injuries. It has three key steps - vasoconstriction, formation of a primary platelet plug, and a secondary fibrin clot formed by the coagulation cascade. The body regulates this process through anticoagulants like antithrombin III, protein C and S, and TFPI to restrict clotting locally. It also activates fibrinolysis through plasmin to limit final clot size.
This document discusses hemostasis, the process by which bleeding is stopped. It describes the two main components: primary hemostasis involving platelet adhesion, aggregation, and plug formation; and secondary hemostasis where insoluble fibrin is generated through coagulation cascade reactions to strengthen the platelet plug. Key terms are defined, including hemostasis, thrombosis, hemorrhage, and coagulopathy. The roles of primary hemostasis, secondary hemostasis, the intrinsic pathway, extrinsic pathway, and common pathway in the coagulation cascade are explained.
This document discusses infarction, which is localized ischemic necrosis of tissue due to decreased blood supply. Infarction can be caused by thrombi, emboli, vasospasm, expansion of atheroma, extrinsic compression of vessels, vessel twisting, or traumatic vessel rupture. There are three main types of infarction: red (hemorrhagic), white (anemic), and septic. Factors that influence infarction development include vulnerability to hypoxia, blood oxygen content, rate of occlusion, and blood supply. Myocardial, pulmonary, and cerebral infarctions are provided as examples and their characteristics and outcomes described.
This document summarizes different types of thrombosis and embolism. It discusses thrombosis, thrombus formation, and the coagulation cascade. It also covers different causes of endothelial injury that can lead to thrombosis, including atherosclerosis, hypertension, diabetes, and smoking. Alterations in blood flow that can promote thrombosis are turbulence, stasis, and hypercoagulability. The document outlines various types of embolism including thromboembolism, fat embolism, gas embolism, and amniotic fluid embolism. It provides details on the pathogenesis, clinical manifestations, and consequences of pulmonary thromboembolism and systemic arterial embolism.
Thrombosis results from an imbalance in the normal hemostatic system where there is inappropriate clot formation. It depends on contributions from Virchow's triad of endothelial injury, abnormal blood flow, and hypercoagulability. Endothelial damage or abnormalities in blood flow like stasis or turbulence allow clots to form. Hypercoagulable states like genetic mutations or inflammation also promote clotting. Thrombi may propagate and cause tissue injury, become organized, or embolize to distant sites. Disseminated intravascular coagulation is a consumptive coagulopathy where widespread microvascular thrombi activate fibrinolysis, initially causing thrombosis but potentially evolving into bleeding.
Hemostasis is the arrest of bleeding, whether it be by normal vasoconstriction (the vessel walls closing temporarily), by an abnormal obstruction (such as a plaque) or by coagulation or surgical means (such as ligation)
This document summarizes hemostasis, the process by which bleeding is stopped. It discusses the three components of hemostasis - extravascular, vascular, and intravascular. The normal hemostasis process involves platelet plug formation and fibrin clot formation via the coagulation cascade. Coagulation factors, platelets, and fibrinogen are involved. Hemostasis is balanced by natural anticoagulants. Genetic or acquired bleeding disorders can result from deficiencies in specific coagulation factors or platelets. Common disorders discussed include hemophilia A/B/C and von Willebrand disease.
The document discusses various hemodynamic disorders including hyperemia, congestion, thrombosis, embolism, and infarction. Hyperemia is an increased blood volume in tissue from vasodilation. Congestion is increased blood volume from impaired venous return. Thrombosis is the formation of a blood clot within vessels. An embolism occurs when a piece of thrombus or other material blocks a vessel. Infarction is tissue death from blocked arteries or veins.
Hemostasis definition, types and steps.
Hemostasis and coagulation physiology and pathology in steps and illustrated in simple way by diagrams.
Intrinsic and extrinsic pathways are mentioned in details.
Platelet function as a corner stone hemostasis in case of endothelial injury or another pathology taht affect endothelium or blood vessels.
Some pharmacological notes about drugs related to hemostasis and its clinical significance.
The document discusses thrombosis and embolism. It defines thrombosis as the formation of a blood clot within a blood vessel and embolism as a detached blood clot that travels through the bloodstream. It covers topics like the mechanisms of hemostasis (clot formation), factors that predispose to thrombosis, morphology of arterial and venous thrombi, types of thrombosis like deep vein thrombosis and their clinical presentations.
Hemostasis and thrombosis involve the regulation of blood clotting. Normal hemostasis maintains blood fluidity but allows clotting at sites of injury. Thrombosis is pathological clotting in uninjured or minimally injured vessels. It involves platelet adhesion and activation, coagulation cascade activation, and fibrin clot formation. Counter-regulatory mechanisms normally limit clotting to the injury site. Abnormalities in blood components, vessel walls, or flow can cause hypercoagulability and thrombosis.
Thrombosis is the formation of a blood clot or thrombus in the circulatory system. A thrombus forms when the normal balance between coagulation and fibrinolysis is disrupted, such as after an injury to the blood vessel wall. Virchow's triad describes the three main factors that contribute to thrombosis: endothelial injury, changes in blood flow, and hypercoagulability. Thrombi can form in the heart, arteries, veins, or microcirculation and may cause complications like ischemic injury, thromboembolism, or organ infarction if left untreated. The fate of a thrombus depends on whether it is resolved by fibrinolysis, organized by the body, continues to grow, or embol
Platelets play a key role in hemostasis, the process of stopping blood loss from damaged blood vessels. They adhere to sites of injury and aggregate to form a platelet plug during primary hemostasis. Secondary hemostasis involves blood coagulation and reinforcement of the platelet plug with a fibrin mesh. Disorders of hemostasis can cause excessive bleeding from thrombocytopenia or platelet dysfunction (primary hemostasis) or coagulation factor deficiencies (secondary hemostasis). Laboratory tests are used to assess platelet count and function as well as coagulation factor levels.
The document discusses recent advances in antithrombotic therapy. It describes the components of thrombus, types of thrombosis, and pathological conditions like stroke and myocardial infarction. Newer antithrombotic agents discussed include direct factor Xa inhibitors, tissue factor inhibitors, and platelet receptor antagonists. These target specific coagulation factors, platelet activation pathways, and inflammation to reduce thrombus formation. However, traditional agents like heparin, coumarins and aspirin remain standard treatments due to side effects and costs of newer drugs. Continued research is needed to develop safer, more effective antithrombotics.
The document discusses recent advances in antithrombotic therapy. It describes the components of thrombus, types of thrombosis, and pathological conditions like stroke and myocardial infarction. Newer antithrombotic agents discussed include direct factor Xa inhibitors, tissue factor inhibitors, and platelet P-selectin inhibitors. These target specific components of the coagulation cascade and inflammatory processes in thrombosis. While promising, currently no single new agent has replaced standards like heparin, warfarin, and aspirin due to limitations like side effects or cost. Continued research is needed to develop safer, more effective antithrombotic drugs.
The document discusses recent advances in antithrombotic therapy. It describes the components of thrombus, types of thrombosis, and pathological conditions like stroke and myocardial infarction. Newer antithrombotic agents discussed include direct factor Xa inhibitors, tissue factor inhibitors, and platelet inhibitors that target receptors like P-selectin, GPVI collagen receptor, and ADP receptors. While these new agents show promise, conventional treatments like heparin, coumarins and aspirin remain standard of care due to side effects and costs of newer therapies. Continued research is needed to develop safer, more effective antithrombotic drugs.
CIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE - THROMBOSISDr. Roopam Jain
This document discusses thrombosis and thrombus formation. It defines thrombosis as the formation of a solid mass or thrombus in the circulation from blood components. It notes that thrombi can cause harmful effects like ischemic injury by decreasing blood flow or thromboembolism by breaking off and lodging in distant vessels. It describes the pathophysiology of thrombus formation including endothelial injury, altered blood flow, hypercoagulability, platelet activation, and coagulation system activation. It discusses different types of thrombi, their morphology, composition and distinguishing features. It also covers hypercoagulable states, causes of thrombosis, and the potential fates of thrombi.
CIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE: THROMBOSISDr. Roopam Jain
1. The document discusses hemodynamic disorders, thromboembolic disease, and shock. It covers topics such as thrombosis, thrombus formation, hypercoagulable states, and the fate of thrombi.
2. Thrombosis is the formation of a solid mass or thrombus in the circulatory system. Virchow's triad describes the key events in thrombus formation - endothelial injury, altered blood flow, and hypercoagulability.
3. Thrombus formation involves platelet activation at the site of injury, release of coagulation factors, and formation of a fibrin clot. Hypercoagulable states increase the risk of developing venous thrombosis.
This document discusses various types of edema, thrombosis, and embolism. It defines edema as increased fluid in the interstitial tissue spaces. Thrombosis is the formation of a thrombus or blood clot within vessels. An embolism occurs when a piece of this thrombus breaks off and travels to lodge in another vessel. Common causes, presentations, and outcomes of these conditions are described.
15-pathology of hemodynamicsHEMODYNAMIC DISORDERS.pptLearta Asani
Edema is excess fluid accumulation in interstitial spaces that can occur systemically or locally. It is caused by increased hydrostatic pressure, reduced plasma oncotic pressure, sodium retention, or lymphatic obstruction. Generalized edema with profound swelling is called anasarca. Thrombosis is the formation of a clot (thrombus) within a blood vessel. It results from an interaction of platelets, damaged endothelial cells, and activation of the coagulation cascade. The major influences predisposing to thrombosis are endothelial injury, blood stasis, and hypercoagulability.
Hemodynamic disorders med- 2011, final iiدكتور مريض
1. Thrombosis is the formation of a blood clot (thrombus) within the circulatory system of a living organism. It is caused by endothelial injury, changes in blood flow, and hypercoagulability according to Virchow's triad.
2. Thrombi form in arteries and veins, and can cause obstruction, ischemia, infarction, or embolization if parts break off. Common sites are the legs, lungs, heart, and brain.
3. Embolism occurs when a thrombus or other mass travels through the bloodstream and blocks a vessel in another part of the body, potentially causing infarction or sepsis. Pulmonary embolism from deep leg vein
Hemodynamic disorders can cause thrombosis through inappropriate activation of hemostasis. Thrombosis is the formation of a blood clot within an intact blood vessel or thrombotic occlusion after minor injury. It results from endothelial injury, abnormal blood flow, or hypercoagulability. Thrombi can propagate and occlude vessels, embolize to obstruct other sites, or dissolve. Complications include pulmonary embolism, deep vein thrombosis, myocardial infarction, and disseminated intravascular coagulation.
Rudolf Virchow identified three main factors that contribute to thromboembolism: venous stasis, hypercoagulability, and endothelial injury. Deep vein thrombosis is the formation of a blood clot in the deep veins, usually in the legs. Signs and symptoms include pain, swelling, redness, and tenderness. Diagnosis involves physical exam, D-dimer test, ultrasound, CT scan, and pulmonary angiogram. Treatment consists of anticoagulants like heparin and warfarin to prevent clot extension and recurrence, as well as thrombolytics, surgery, and IVC filters in some cases.
The document discusses various hemodynamic disorders including edema, hemorrhage, thrombosis, embolism, and shock. It defines each condition and describes their mechanisms and presentations. Edema is an accumulation of fluid in tissues and can be caused by increased hydrostatic pressure, decreased oncotic pressure, lymphatic obstruction, or sodium retention. Hemorrhage is the leakage of blood from vessels, while thrombosis is the formation of a clot within vessels. Embolism occurs when a clot or other material travels through the bloodstream and blocks a vessel in another part of the body.
This document discusses hemostasis and blood transfusion. It begins with definitions of hemostasis and describes the five stages of hemostasis: vascular phase, platelet phase, coagulation phase, clot retraction, and fibrinolysis. It then discusses investigations for disorders of hemostasis, including clinical evaluation and laboratory tests. Major disorders of hemostasis are outlined, including inherited and acquired issues with blood vessels, platelets, and coagulation. The document also covers blood components, indications for component therapy, and potential complications of blood transfusion.
This document discusses drugs used to treat thrombotic disorders. It begins by defining hemostasis and blood coagulation, noting they involve platelets, clotting factors, and a delicate balance. Drugs that modulate this balance are then discussed, including antiplatelets like aspirin, anticoagulants like warfarin and heparin, and fibrinolytics. The coagulation cascade and its initiation by tissue factor are described. Natural anticoagulants like antithrombin and the protein C pathway are also outlined. Finally, fibrinolysis and its regulation are summarized.
Disseminated intravascular coagulation (DIC) is a pathological condition where widespread blood clot formation occurs throughout the small blood vessels of the body. It can be acute, subacute, or chronic. DIC results from the activation of coagulation pathways due to factors like sepsis, trauma, malignancy, or obstetric complications. This leads to fibrin deposition, thrombosis, multi-organ failure, and bleeding manifestations as clotting factors are depleted. Treatment involves controlling the underlying condition, replacing clotting factors, and using anticoagulants.
1. The document discusses various vascular pathologies including hyperemia, congestion, thrombosis, embolism, and infarction.
2. It describes the morphology and causes of different types of hyperemia, congestion, thrombosis, pulmonary and non-pulmonary embolism, and hemorrhagic vs. white infarcts.
3. The roles of the endothelium, platelets, and coagulation cascade in thrombosis are examined, as are the potential fates of a thrombus and clinical effects of embolism.
Similar to Thrombosis - Pathology by Dr.Pawan (20)
Calcium homeostasis is regulated by parathyroid hormone (PTH) and vitamin D. Vitamin D deficiency can lead to rickets in children, causing softening and weakening of bones. Symptoms of rickets include bowed legs, skull deformities, enlarged wrists, and delayed dental eruption. Diagnosis is made based on lab findings of low calcium and phosphate with elevated alkaline phosphatase and PTH. Treatment involves high dose vitamin D and calcium supplementation. Genetic causes of rickets include vitamin D resistant rickets, hypophosphatemic rickets, and X-linked hypophosphatemia. Surgical correction may be needed for severe bone deformities after medical treatment.
1. Pneumonia is an inflammatory lung condition caused by infection, usually bacterial, that is characterized by consolidation of the lung tissue.
2. Community-acquired pneumonia is defined as pneumonia acquired outside of a hospital setting, within 14 days of symptoms. Healthcare-associated pneumonia refers to pneumonia acquired in other healthcare settings such as nursing homes.
3. Hospital-acquired pneumonia refers to pneumonia that develops 48 hours or more after admission to the hospital. Risk factors include mechanical ventilation, underlying diseases, and antibiotic resistance of hospital-acquired pathogens.
Factors such as age, weight, gender, and genetic variations can modify how individuals respond to drugs. Drug-related factors like dosage, interactions, and tolerance also impact outcomes. Adverse drug reactions may be predictable based on pharmacology or unpredictable due to immune or genetic factors. Close monitoring of drug therapy is needed to optimize benefits and prevent harm.
The document provides an overview of the Indian Public Health Standards (IPHS) for primary health centers and urban primary health centers. It discusses the importance and objectives of the IPHS, the types of primary health facilities, population norms, general principles, and criteria for compliance. It also outlines the essential services that should be provided, including maternal and child health services, family planning services, management of communicable diseases, and community outreach programs. Infrastructure requirements for the primary health centers are also covered.
Pharmacology of Adrenergic System , Agonist and Antagonist Drugs by Dr. PawanDr. Pawan Kumar B
This document discusses the adrenergic system and its divisions. It describes the sympathetic nervous system, also called the adrenergic nervous system, which uses norepinephrine and epinephrine as neurotransmitters. It is involved in the "fight or flight" response and increases blood pressure, blood flow to muscles, and glycogen stores to prepare the body for stress. The document outlines the different types of adrenergic receptors, including alpha-1, alpha-2, beta-1, beta-2, and beta-3 receptors, and their locations and functions. It also discusses adrenergic drugs that either stimulate or block these receptors, their mechanisms and indications.
Congestive Heart Failure and Drugs used in CCF by Dr. PawanDr. Pawan Kumar B
Congestive heart failure occurs when the heart is unable to pump enough blood to meet the body's needs or receive blood returning to the heart. It is classified as left or right, chronic or acute, and low or high output failure. Common causes include hypertension, heart attacks, congenital heart disease, and cardiomyopathy. Treatment involves reducing the workload on the heart through medications like diuretics, ACE inhibitors, beta-blockers, and vasodilators to decrease preload and afterload and manage fluid retention and edema. The goal is to improve symptoms and prolong life for patients with congestive heart failure.
Atropine is a competitive muscarinic receptor antagonist that is used for its anticholinergic effects. It blocks acetylcholine action in the autonomic nervous system and central nervous system. Atropine is used to treat bradycardia, bronchospasm, asthma, motion sickness, and as an antidote for organophosphate poisoning. Common adverse effects include dry mouth, blurred vision, constipation, tachycardia, and delirium at high doses.
This document outlines the procedures and steps for performing a craniotomy, which involves perforating the fetal skull to facilitate delivery of a dead fetus when normal vaginal delivery is not possible. The key steps are: 1) placing fingers on the proposed perforation site on the skull; 2) using an instrument to perforate and create a cruciate incision in the skull; 3) evacuating the brain matter and extracting the fetus by applying traction. Post-procedure care and potential complications are also described. The procedure requires surgical skills and carries risks if not performed correctly.
1) The document describes the role of an Accredited Social Health Activist (ASHA) in India, who works in communities to create awareness on health.
2) An ASHA receives training on public health and works to provide basic healthcare services, information on existing health services, and mobilizes communities for immunization programs and utilization of health services.
3) Key responsibilities of an ASHA include raising awareness, counseling, mobilizing communities, escorting those requiring treatment, providing primary medical care, maintaining a drug depot, registering births and deaths, and promoting sanitation.
This document provides information about tattoos, including their history, types, techniques, and forensic importance. It notes that tattoos have been practiced since ancient times, with the first known tattoo dating back 4,000 BC. It describes different types like traumatic, amateur, professional, cosmetic, and medical tattoos. Techniques for applying tattoos as well as removing them are outlined. Tattoos can be forensically important for identifying individuals or providing clues about religion, culture, criminal affiliations, and medical conditions. A case example is given where a tattoo helped identify a victim's severed arm found inside a shark.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
3. Process of formation of solid mass
in circulation from the constituents
of flowing blood.
The mass is called as THROMBUS.
4. Bloodclot
• Mass of
coagulated
blood
formed in
vitro.
• E.g. in a test
tube.
Hematoma
• Extra
vascular
accumulation
of blood
clot.
• E.g. into the
tissues.
Haemostaticplugs
• blood clot
formed in
healthy
individual at
the site of
bleeding.
• E.g. in injury
to blood
vessel.
8. Endothelium
Antithrombotic factors
Antiplatelet
Adenosine
diphosphatase ( ADP)
Prostacyclin and nitric
oxide (also
vasodilatation)
Anticoagulant
Heparin-like molecules
(activate antithrombin
III)
Thrombomodulin
(activates protein C)
Protein S synthesis
Fibrinolytic
t-PA
Procoagulant factors
Production of vWF
Production of tissue factor
Binding of factors IXa & Xa.
9. Vascular Injury
Major significance in formation of arterial, cardiac thrombi.
Exposes sub
endothelial
connective tissue.
Vasoconstriction
of small blood
vessels.
Collagen, fibronectin,
Elastin
To reduce Blood Loss
10. Predisposing factors
Endothelial injury in MI , myocarditis , Cardiac Surgery.
Ulcerated plaques in advanced atherosclerosis.
Arterial diseases.
D.M.
Chemical agents
Endogenous : Endotoxins , hypercholesterolemia
Exogenous : Cigarette smoke
13. Exposes the underlying basement membrane ECM
Platelets adhere to the ECM via vWF through Gp1B receptors
Platelets provide a phospholipids surface for coagulation
Activation of platelet cause degranulation , secretes
calcium that activates coagulation proteins
ADP which mediates further platelet aggregation
TXA2 which increases platelet activation and cause
vasoconstriction.
14. Contd…
ADP
primary haemostatic plug by activating Gp IIb - IIIa
receptors
fibrinogen binding and cross linking.
The formation of definitive secondary plug requires
activation of thrombin to cleave fibrinogen and form
polymerized fibrin via the coagulation cascade.
17. Act on clotting factors to oppose formation of thrombin.
e.g.antithrombin III, Protein C , C1 inactivator.
Regulation of coagulation factor
Protease inhibitors
21. HYPERCOAGUBILITY OF BLOOD
primary (genetic) factors
Common
• Factor V mutation (factor V Leiden)
• Prothrombin mutation
• 5,10-Methylenetetrahydrofolate reductase
• Increased levels of factors VIII, IX, XI, or fibrinogen
Rare
• Antithrombin III deficiency
• Protein C & S deficiency.
24. Hypercoagubility may occur by
coagulation factors
e.g. fibrinogen,
Prothrombin
platelet count &
adhesiveness.
coagulation inhibitors
e.g. Antithrombin III,
fs products.
27. ORIGIN OF THROMBI
Common in atrial appendages (right atrium, mitral, aortic valves) –
Infective Endocarditis
Mural & Non-Occlusive.
Ball-valve thrombus : large round thrombus obstructing mitral valve
Agonal thrombi – shortly before death – occur either or both ventricles.
CARDIAC THROMBI
28. Feature Arterialthrombi Venousthrombi
Blood flow Formed in rapidly flowing
blood of arteries & heart
Slow moving blood in veins
Sites Common in aorta ,coronary,
cerebral, iliac, femoral,
renal & mesenteric arteries.
Common in superficial
varicose veins, deep leg
veins, popliteal, femoral &
iliac veins
Thrombogenesis Formed following
endothelial cell injury .
e.g. in atherosclerosis
Formed following venous
stasis e.g. in abdominal
operations, child-birth
VASCULAR THROMBI
29. Feature ArterialThrombi VenousThrombi
Developmen
t
Usually mural,
not occluding the lumen
completely,
may propagate
Usually occlusive,
take the cast of vessel in
which formed,
may propagate in both
directions
Macroscopy Grey-white, friable with lines
of Zahn on surface.
Red-blue with fibrin strands &
lines of Zahn.
Microscopy Distinct lines of Zahn composed
of platelets, with entangled
red and white blood cells
Lines of Zahn with more
abundant red cells.
Effects Ischemia leading to infarcts .
e.g. in heart brain etc
Thromboemboilsm,
oedema,
skin ulcers,
poor wound hearing
32. CAPILLARY THROMBI
Minute thrombi composed mainly composed of packed red cells are
formed in capillaries in acute inflammatory lesions, vasculitis, DIC.
35. ORGANISATION
Phagocytic cells appear. Phagocytose fibrin & cell debris.
Proteolytic enzymes liberated leukocytes and endothelial cells,
digests coagulum.
Capillaries grow into thrombus & fibroblasts invade thrombus.
Fibro vascular granulation tissue formed , dense & less
vascular covered over by endothelial cells.
Recanalisation occurs.
36.
37.
38. Large cardiac thrombi : Sudden death by mechanical obstruction of blood flow
or Thromboembolism.
Arterial thrombi : Ischemic necrosis may lead to gangrene.
Coronary artery thrombosis may lead to sudden death.
Capillary thrombi : DIC.
Clinical effects
39. Venous thrombi (Phlebothrombosis)
Thromboembolism
Oedema
Poor wound healing
Skin ulcer
Painful thrombosed veins (Thrombophlebitis)
Painful white leg (phlegma alba dolens)